Lobe Sciences Ltd. (CVE:LOBE) | Finanzwire

Basculer en Français

9795	Companies
196302	Keywords
127335	Articles
104380	Press releases

Home
Companies
Lobe Sciences Ltd.

PRESS RELEASE

published on 07/29/2025 at 06:10, 6 months 5 days ago

Lobe Sciences Announces $341,425 CAD Private Placement for General Corporate Purposes
Lobe Sciences announces non-brokered private placement offering of common shares for gross proceeds, focusing on therapeutics for rare diseases

Private Placement Biopharmaceutical Therapeutics Rare Diseases Lobe Sciences
PRESS RELEASE

published on 07/29/2025 at 06:08, 6 months 5 days ago

Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
Lobe Sciences partners with ArcStone Securities to enhance capital market strategy, aiming to increase visibility and deliver shareholder value through scientific innovation and strategic collaboration in North American markets

Capital Markets Biopharmaceutical Investment Community Lobe Sciences ArcStone Securities
BRIEF

published on 07/17/2025 at 04:00, 6 months 17 days ago

Lobe Sciences Ltd. Settles Debt with Gibbsons P.C.

Common Shares Issuance Debt Settlement Biopharmaceutical Company Canadian Securities Innovative Treatments
PRESS RELEASE

published on 07/17/2025 at 03:55, 6 months 17 days ago

Lobe Sciences Ltd. Announces Debt Settlement
Lobe Sciences settles debt with Gibbsons Law P.C. by issuing 546,206 common shares at CAD$0.02123/share. The shares were issued on May 13, 2025, subject to regulatory hold periods

Common Shares Debt Settlement Biopharmaceutical Lobe Sciences Regulatory Hold Periods
BRIEF

published on 07/08/2025 at 06:06, 6 months 26 days ago

Lobe Sciences Secures European Patent for Sickle Cell Disease Treatment

European Patent Sickle Cell Disease DHA Composition Altemia® Biopharmaceutical Expansion
PRESS RELEASE

published on 07/08/2025 at 06:01, 6 months 26 days ago

Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
Lobe Sciences secures European Unitary Patent EP4117446 across 17 EU member states for innovative Altemia(R) Medical Food Formula designed to manage Sickle Cell Disease, supporting global expansion strategy

Global Expansion Lobe Sciences Sickle Cell Disease European Unitary Patent Altemia Medical Food Formula
BRIEF

published on 06/18/2025 at 06:03, 7 months 15 days ago

Lobe Sciences Advances Conjugated Psilocin Development with Cynaptec Spin-Out

Conjugated Psilocin Cynaptec Pharmaceuticals Chronic Cluster Headaches Sickle Cell Disease Biopharmaceutical Investments
PRESS RELEASE

published on 06/18/2025 at 05:58, 7 months 15 days ago

Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M

Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™
BRIEF

published on 06/03/2025 at 12:15, 8 months ago

Lobe Sciences Appoints Yong Yao as CFO for Strategic Initiatives

Strategic Growth Operational Expansion Biotech Finance Lobe Sciences Yong Yao
PRESS RELEASE

published on 06/03/2025 at 12:10, 8 months ago

Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
Lobe Sciences Ltd. appoints Mr. Yong Yao as CFO & EVP, leveraging his 25 years of finance & biotech experience to drive financial strategy & growth. Strategic shift to full-time financial leadership

Chief Financial Officer Executive Vice President Finance Strategy Lobe Sciences Yong Yao

Accesswire

Published on 02/03/2026 at 15:00, 4 hours 24 minutes ago

Vox Royalty Announces Record 2025 Annual and Quarterly Receipts and Exceeds Annual Guidance
Published on 02/03/2026 at 14:29, 4 hours 55 minutes ago

Worksport Ltd. Announces Strategic Partnership With Potomac International Partners to Accelerate Federal Government and Commercial Market Adoption of Clean Energy Ecosystem
Published on 02/03/2026 at 13:58, 5 hours 26 minutes ago

QNX and Haleytek Join Forces to Deliver Software-Defined Audio for Volvo Cars' EX60 EV SUV
Published on 02/03/2026 at 13:30, 5 hours 54 minutes ago

Alset AI's Lyken.AI Secures Cloud Compute Services Purchase Order from Leading Multinational Technology and Telecommunications Company
Published on 02/03/2026 at 13:30, 5 hours 54 minutes ago

Lahontan Selects RESPEC and Kappes Cassiday to Update Santa Fe Mineral Resource Estimate and PEA

View all ACCESSWIRE

EQS Group

Published on 02/03/2026 at 19:06, 17 minutes ago

Quarterly Activities Report for the period ending 31 December 2025
Published on 02/03/2026 at 18:39, 44 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/03/2026 at 18:30, 53 minutes ago

TECNIMONT (MAIRE) AND BAKER HUGHES TO COLLABORATE ON LNG INITIATIVES GLOBALLY
Published on 02/03/2026 at 18:25, 58 minutes ago

Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 02/03/2026 at 18:25, 58 minutes ago

Midea Building Technologies Showcases "Smart in One" Integrated Building Solutions at AHR Expo 2026

Les Echos

Published on 02/03/2026 at 17:45, 1 hour 39 minutes ago

Revenue growth in 2025 to €11.2m (+5%)
Published on 02/03/2026 at 08:00, 11 hours 24 minutes ago

EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 11 hours 24 minutes ago

Neoen launches three new solar farms in France with a total capacity of 230 MWp
Published on 02/02/2026 at 18:23, 1 day 1 hour ago

Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 1 day 1 hour ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE